Mercer Global Advisors »

Syndax Pharmaceuticals shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $552k 24k 23.36
2025-12-31 $374k 18k 21.01

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Apple (AAPL)
Dimensional Etf Trust Intl Core Equity (DFIC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Internatnal Val (DFIV)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Intl High Profit (DIHP)

View all positions for Mercer Global Advisors

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Vanguard Group
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Deerfield Management Company
Eversept Partners
Kingdon Capital Management
Hood River Capital Management
Geode Capital Management
Franklin Resources
Point72 Asset Management
Elmind Capital

View all funds holding Syndax Pharmaceuticals